CASSANO, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 3.692
EU - Europa 3.357
AS - Asia 2.912
SA - Sud America 402
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 10.415
Nazione #
US - Stati Uniti d'America 3.636
CN - Cina 1.066
SG - Singapore 962
IE - Irlanda 938
UA - Ucraina 635
SE - Svezia 436
IT - Italia 361
BR - Brasile 345
RU - Federazione Russa 280
HK - Hong Kong 269
DE - Germania 212
IN - India 178
FR - Francia 167
FI - Finlandia 126
VN - Vietnam 124
TR - Turchia 119
KR - Corea 79
GB - Regno Unito 65
AT - Austria 44
CA - Canada 25
ID - Indonesia 21
MX - Messico 17
AR - Argentina 16
BE - Belgio 16
NL - Olanda 15
PL - Polonia 15
BD - Bangladesh 14
ZA - Sudafrica 14
EC - Ecuador 13
JP - Giappone 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 10
IQ - Iraq 10
MA - Marocco 10
EU - Europa 8
LT - Lituania 8
CL - Cile 6
UZ - Uzbekistan 6
VE - Venezuela 6
CH - Svizzera 5
CO - Colombia 5
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
TH - Thailandia 4
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
ES - Italia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
JO - Giordania 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
TV - Tuvalu 2
AL - Albania 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SO - Somalia 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
ZW - Zimbabwe 1
Totale 10.415
Città #
Dublin 937
Chandler 536
Singapore 488
Jacksonville 428
Dearborn 325
Nyköping 291
Hong Kong 268
Beijing 253
Ashburn 234
Nanjing 205
Dallas 191
Santa Clara 128
Wilmington 104
Princeton 98
New York 84
Nanchang 71
Ann Arbor 70
The Dalles 69
San Mateo 63
Helsinki 53
Los Angeles 50
Moscow 50
Des Moines 49
Boardman 48
Shenyang 47
Rome 46
Munich 45
Hebei 44
Ho Chi Minh City 41
Tianjin 39
Hilden 36
Woodbridge 33
Jiaxing 32
Foggia 30
Kunming 30
São Paulo 30
Vienna 30
Pune 29
Hangzhou 28
Jinan 28
Guangzhou 26
Seattle 19
Bari 18
Changsha 18
Hanoi 18
Ningbo 17
Brussels 16
Columbus 15
Milan 15
Brooklyn 14
Wuhan 14
Zhengzhou 14
Warsaw 13
Dong Ket 12
Falls Church 12
San Severo 12
Chicago 11
Shanghai 11
Düsseldorf 10
Jakarta 10
Lanzhou 10
Norwalk 10
Rio de Janeiro 10
San Francisco 10
Washington 10
Atlanta 9
Auburn Hills 9
Chennai 9
Johannesburg 9
West Jordan 9
Denver 8
Houston 8
Naples 8
Porto Alegre 8
Redwood City 8
Tokyo 8
Toronto 8
Boston 7
Council Bluffs 7
Haiphong 7
Hefei 7
New Delhi 7
Nuremberg 7
Philadelphia 7
Santeramo In Colle 7
Stockholm 7
Ankara 6
Curitiba 6
Falkenstein 6
Kocaeli 6
Orange 6
Paris 6
Taizhou 6
Tashkent 6
Venice 6
Belo Horizonte 5
Betim 5
Biên Hòa 5
Brno 5
Campinas 5
Totale 6.249
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 199
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 154
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 144
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 141
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 139
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 138
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 137
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 133
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 131
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 130
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 127
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 126
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 126
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 126
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 125
Antinutritional effects of fumonisin B1 and pathophysiological consequences 125
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 125
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 124
Novel codrugs with GABAergic activity for dopamine delivery in the brain 124
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 119
Aberrant insulin signaling in Alzheimer's disease: current knowledge 119
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 118
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 117
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 117
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 117
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 115
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 114
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 114
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 113
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 113
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 113
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 113
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 112
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 110
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 109
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 109
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 109
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 107
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 106
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 106
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 105
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 105
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 104
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 103
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 103
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 101
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 101
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 100
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 99
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 98
Role of the area postrema in the hypophagic effects of oleoylethanolamide 97
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 97
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 96
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 95
Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence [Biomed. Pharmacother. 188 (2025) 118199] 94
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 94
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 94
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 93
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 92
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 92
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 91
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 91
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 91
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 90
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 89
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 89
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 87
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 87
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 87
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 86
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 86
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 85
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 85
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 84
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 84
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 83
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 82
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 82
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 82
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 82
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 81
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 81
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 80
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 77
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 77
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 76
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 76
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 75
Lung histopathological findings in COVID-19 disease - a systematic review 73
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 73
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 72
From obesity resistance to obesity prediction and prevention? 72
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 72
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 71
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 68
Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats 68
Oxidative Stress in Aging Brain: Nutritional and Pharmacological Interventions for Neurodegenerative Disorders 67
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 67
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 65
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 64
Totale 10.085
Categoria #
all - tutte 57.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021458 0 0 0 0 0 70 112 13 115 131 1 16
2021/2022538 64 11 4 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/20251.916 85 19 79 64 72 234 231 95 468 151 213 205
2025/20261.850 246 304 510 511 259 20 0 0 0 0 0 0
Totale 10.844